Rubicon Biotechnology
Focus: Rubicon Biotechnology is a early-stage generics and specialty pharma company founded in 2021, headquartered in Irvine, CA, with a portfolio of established generic medications across cardiovascular, neurology, and psychiatry indications.
Profile data last refreshed 19h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Rubicon Biotechnology
AI assessmentNot HiringNo open roles listed right now. Follow Rubicon Biotechnology to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Rubicon Biotechnology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$370K Part DStable
Growth
Flagship product and sole revenue driver (98% concentration); recently launched NDA formulation indicates recent market entry or reformulation.
Help build intelligence for Rubicon Biotechnology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.